---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-032347"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2023-09-12T23:59:59+00:00"
generated_at: "2026-06-10T20:43:42.930103+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics stockholders elect directors and approve all proposals at annual meeting

## Summary
- Four director nominees elected: Hankey, Stroever, Lucera, Angle; broker non-votes of 578,270 for each.
- Advisory vote on executive compensation approved: 904,764 for, 84,094 against, 307,376 abstentions.
- Advisory frequency vote selects every year (958,400 votes); board adopts annual say-on-pay policy.
- Ratification of Weinberg & Company as auditor for FY2023: 1,513,051 for, 61,316 against.
- First Amendment to 2015 Equity Incentive Plan approved: 863,931 for, 123,150 against, 309,153 abstentions.

## SEC filing metadata
- accession: 0001493152-23-032347
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2023-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-032347
- JSON: https://secwatch.observer/filing/0001493152-23-032347.json
- Plain text: https://secwatch.observer/filing/0001493152-23-032347.txt

## Key facts
- Shareholder Votes
  Bone Biologics Corp shareholders approved Ratification of Weinberg & Company, P.A. as independent auditor at the 2023-09-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-09-12
  source text: The Company’s stockholders ratified the appointment of Weinberg & Company, P.A. as the Company’s independent registered public accounting firm
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm
- Shareholder Votes
  Bone Biologics Corp shareholders approved Advisory vote on executive compensation at the 2023-09-12 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-09-12
  source text: The Company’s stockholders approved, on an advisory basis, the Company’s executive compensation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm
- Shareholder Votes
  Bone Biologics Corp shareholders approved Frequency of future say-on-pay votes at the 2023-09-12 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-09-12
  source text: The Company’s stockholders approved, on an advisory basis, that future say-on-pay votes should occur every year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm
- Shareholder Votes
  Bone Biologics Corp shareholders approved Approval of First Amendment to 2015 Equity Incentive Plan at the 2023-09-12 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-09-12
  source text: The Company’s stockholders approved the First Amendment to the Company’s 2015 Equity Incentive Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm
- Shareholder Votes
  Bone Biologics Corp shareholders approved Election of directors at the 2023-09-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-09-12
  source text: The Company’s stockholders elected the following four director nominees to serve until the date of the next Annual Meeting
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.